Skip to main content

Peer Review reports

From: SESOTHO trial (“Switch Either near Suppression Or THOusand”) – switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa

Original Submission
28 Sep 2017 Submitted Original manuscript
4 Oct 2017 Author responded Author comments - Alain Amstutz
Resubmission - Version 2
4 Oct 2017 Submitted Manuscript version 2
9 Jan 2018 Author responded Author comments - Alain Amstutz
Resubmission - Version 3
9 Jan 2018 Submitted Manuscript version 3
17 Jan 2018 Author responded Author comments - Alain Amstutz
Resubmission - Version 4
17 Jan 2018 Submitted Manuscript version 4
Publishing
29 Jan 2018 Editorially accepted
12 Feb 2018 Article published 10.1186/s12879-018-2979-y

You can find further information about peer review here.

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us